
|Videos|November 1, 2017
Treatments on the Horizon in NETs
Author(s)Matthew Kulke, MD
Matthew Kulke, MD, director, Neuroendocrine and Carcinoid Tumors Program, Dana-Farber Cancer Institute, discusses treatment options on the horizon in the treatment of neuroendocrine tumors (NETs) during the 2017 NANETS Symposium.



















